ESC2025 Premium Access

Real-world treatment patterns in newly diagnosed heart failure patients stratified by ejection fraction subtype in Japan

Congress Presentation

About the speaker

Ms Rachel Knapp

Berlin (Germany)
0 follower

7 more presentations in this session

EVOLUTION-HF DEallEF: a non-interventional study program of patients with heart failure and initiated on dapagliflozin: results of 1st interim analysis

Speaker: Professor M. Paul (Muenster, DE)

Thumbnail

Association between calcium channel blockers prescription and outcome according to left ventricular ejection fraction: data from a real-world heart failure population

Speaker: Doctor M. Gori (Bergamo, IT)

Thumbnail

Outpatient diuretic use in patients with baroreflex activation therapy

Speaker: Doctor L. Straw (Columbia, US)

Thumbnail

Active vs passive best-practice alerts to improve guideline-directed lipid-lowering therapy intensification in patients with recent myocardial infarction and elevated LDL-C

Speaker: Doctor D. Karalis (Philadelphia, US)

Thumbnail

Prognostic impact of maximum vasodilation therapy in heart failure

Speaker: Doctor C. Santos Aragao (Aracaju, BR)

Thumbnail

Access the full session

Heart failure in the real world

Speakers: Ms R. Knapp, Professor M. Paul, Doctor M. Gori, Doctor L. Straw, Doctor D. Karalis...
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations